Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-015271
Filing Date
2025-06-02
Accepted
2025-06-02 18:05:06
Documents
1
Period of Report
2025-05-29

Document Format Files

Seq Description Document Type Size
1 form4-06022025_060603.html 4  
1 form4-06022025_060603.xml 4 10248
  Complete submission text file 0001415889-25-015271.txt   11730
Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Issuer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address INCYTE CORPORATION EXPERIMENTAL STATION RTE 141 & HENRY CLAY RD. BLDG E336 WILMINGTON DE 19880
Business Address
Daly James M (Reporting) CIK: 0001560782 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50768 | Film No.: 251016443